PXMD (PaxMedica) FCF Yield %: -12,093.65 (As of Jun. 30, 2026)


What is PaxMedica FCF Yield %?

PaxMedica PXMD FCF Yield % is -12,093.65 as of Jun. 30, 2026.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, PaxMedica's Trailing 12-Month Free Cash Flow is $-7.62 Mil, and Market Cap is $0.06 Mil. Therefore, PaxMedica's FCF Yield % for today is -12,093.65%.

The historical rank and industry rank for PaxMedica's FCF Yield % or its related term are showing as below:

PXMD' s FCF Yield % Range Over the Past 10 Years
Min: -12093.65   Med: 0   Max: 0
Current: -12093.65

PXMD's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -9.62 vs PXMD: -12093.65

PaxMedica's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

PaxMedica FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

PaxMedica FCF Yield % Related Terms

PaxMedica FCF Yield % Historical Data

* Premium members only.

The historical data trend for PaxMedica's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PaxMedica FCF Yield % Chart

PaxMedica Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial 0.00 0.00 0.00 -24.85 -192.22

PaxMedica Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -178.57 -186.84 -322.30 -307.59 -211.25

PXMD vs BTAX, NBIO, ARTHQ: FCF Yield % Comparison

For the Biotechnology subindustry, PaxMedica's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PaxMedica FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PaxMedica's FCF Yield % distribution charts can be found below:

* The bar in red indicates where PaxMedica's FCF Yield % falls into.


PaxMedica FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

PaxMedica's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-10.769 / 5.602557
=-192.22%

PaxMedica's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.632 * 4 / 1.19669
=-211.25%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -12,093.65 mean?
PaxMedica (PXMD) has a FCF Yield % of -12,093.65 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PaxMedica and its competitors.
Is PaxMedica's FCF Yield % too high?
PaxMedica's current FCF Yield % is -12,093.65.
How does PaxMedica's FCF Yield % compare to BTAX and NBIO?
PaxMedica's FCF Yield % of -12,093.65 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PaxMedica and its competitors. PaxMedica's current FCF Yield % is -12,093.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PaxMedica stock overvalued right now?
PaxMedica (PXMD) has a current FCF Yield % of -12,093.65. The current FCF Yield % is -12,093.65. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For PaxMedica (PXMD), the current FCF Yield % is -12,093.65 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PaxMedica Business Description

Address 303 South Broadway, Suite 125, Tarrytown, NJ, USA, 10591
PaxMedica Inc is a clinical-stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including autism spectrum disorder (ASD), to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a debilitating physical and cognitive disorder believed to be viral in origin and now with rising incidence globally due to the long term effects of SARS-CoV-2 (COVID-19). The company's product candidate under development is PAX-101, an intravenous formulation of suramin, which it is developing for multiple indications, including East African HAT, ASD, ME/CFS, and LCS.